patient,gene,variant,disease,level,therapy
TCGA-D3-A2JG,BRAF,V600E,SKCM,1,Vemurafenib
TCGA-D3-A2JG,BRAF,V600E,SKCM,1,Vemurafenib_Atezolizumab_Cobimetinib
TCGA-D3-A2JG,BRAF,V600E,SKCM,1,Dabrafenib_Trametinib
TCGA-D3-A2JG,BRAF,V600E,SKCM,1,Dabrafenib
TCGA-D3-A2JG,BRAF,V600E,SKCM,1,Encorafenib_Binimetinib
TCGA-D3-A2JG,BRAF,V600E,SKCM,1,Trametinib
TCGA-D3-A2JG,BRAF,V600E,SKCM,1,Vemurafenib_Cobimetinib
TCGA-D3-A2JG,BRAF,V600E,SKCM,3,Encorafenib_Cetuximab
TCGA-D3-A2JG,BRAF,V600E,SKCM,3,Selumetinib
TCGA-D3-A2JG,BRAF,V600E,SKCM,3,Encorafenib_Panitumumab
TCGA-D9-A4Z2,BRAF,V600E,SKCM,1,Vemurafenib
TCGA-D9-A4Z2,BRAF,V600E,SKCM,1,Vemurafenib_Atezolizumab_Cobimetinib
TCGA-D9-A4Z2,BRAF,V600E,SKCM,1,Dabrafenib_Trametinib
TCGA-D9-A4Z2,BRAF,V600E,SKCM,1,Dabrafenib
TCGA-D9-A4Z2,BRAF,V600E,SKCM,1,Encorafenib_Binimetinib
TCGA-D9-A4Z2,BRAF,V600E,SKCM,1,Trametinib
TCGA-D9-A4Z2,BRAF,V600E,SKCM,1,Vemurafenib_Cobimetinib
TCGA-D9-A4Z2,BRAF,V600E,SKCM,3,Encorafenib_Cetuximab
TCGA-D9-A4Z2,BRAF,V600E,SKCM,3,Selumetinib
TCGA-D9-A4Z2,BRAF,V600E,SKCM,3,Encorafenib_Panitumumab
TCGA-EB-A5FP,BRAF,V600E,SKCM,1,Vemurafenib
TCGA-EB-A5FP,BRAF,V600E,SKCM,1,Vemurafenib_Atezolizumab_Cobimetinib
TCGA-EB-A5FP,BRAF,V600E,SKCM,1,Dabrafenib_Trametinib
TCGA-EB-A5FP,BRAF,V600E,SKCM,1,Dabrafenib
TCGA-EB-A5FP,BRAF,V600E,SKCM,1,Encorafenib_Binimetinib
TCGA-EB-A5FP,BRAF,V600E,SKCM,1,Trametinib
TCGA-EB-A5FP,BRAF,V600E,SKCM,1,Vemurafenib_Cobimetinib
TCGA-EB-A5FP,BRAF,V600E,SKCM,3,Encorafenib_Cetuximab
TCGA-EB-A5FP,BRAF,V600E,SKCM,3,Selumetinib
TCGA-EB-A5FP,BRAF,V600E,SKCM,3,Encorafenib_Panitumumab
TCGA-EE-A3AG,BRAF,V600E,SKCM,1,Vemurafenib
TCGA-EE-A3AG,BRAF,V600E,SKCM,1,Vemurafenib_Atezolizumab_Cobimetinib
TCGA-EE-A3AG,BRAF,V600E,SKCM,1,Dabrafenib_Trametinib
TCGA-EE-A3AG,BRAF,V600E,SKCM,1,Dabrafenib
TCGA-EE-A3AG,BRAF,V600E,SKCM,1,Encorafenib_Binimetinib
TCGA-EE-A3AG,BRAF,V600E,SKCM,1,Trametinib
TCGA-EE-A3AG,BRAF,V600E,SKCM,1,Vemurafenib_Cobimetinib
TCGA-EE-A3AG,BRAF,V600E,SKCM,3,Encorafenib_Cetuximab
TCGA-EE-A3AG,BRAF,V600E,SKCM,3,Selumetinib
TCGA-EE-A3AG,BRAF,V600E,SKCM,3,Encorafenib_Panitumumab
TCGA-EB-A42Z,BRAF,V600E,SKCM,1,Vemurafenib
TCGA-EB-A42Z,BRAF,V600E,SKCM,1,Vemurafenib_Atezolizumab_Cobimetinib
TCGA-EB-A42Z,BRAF,V600E,SKCM,1,Dabrafenib_Trametinib
TCGA-EB-A42Z,BRAF,V600E,SKCM,1,Dabrafenib
TCGA-EB-A42Z,BRAF,V600E,SKCM,1,Encorafenib_Binimetinib
TCGA-EB-A42Z,BRAF,V600E,SKCM,1,Trametinib
TCGA-EB-A42Z,BRAF,V600E,SKCM,1,Vemurafenib_Cobimetinib
TCGA-EB-A42Z,BRAF,V600E,SKCM,3,Encorafenib_Cetuximab
TCGA-EB-A42Z,BRAF,V600E,SKCM,3,Selumetinib
TCGA-EB-A42Z,BRAF,V600E,SKCM,3,Encorafenib_Panitumumab
TCGA-EB-A3Y6,BRAF,V600E,SKCM,1,Vemurafenib
TCGA-EB-A3Y6,BRAF,V600E,SKCM,1,Vemurafenib_Atezolizumab_Cobimetinib
TCGA-EB-A3Y6,BRAF,V600E,SKCM,1,Dabrafenib_Trametinib
TCGA-EB-A3Y6,BRAF,V600E,SKCM,1,Dabrafenib
TCGA-EB-A3Y6,BRAF,V600E,SKCM,1,Encorafenib_Binimetinib
TCGA-EB-A3Y6,BRAF,V600E,SKCM,1,Trametinib
TCGA-EB-A3Y6,BRAF,V600E,SKCM,1,Vemurafenib_Cobimetinib
TCGA-EB-A3Y6,BRAF,V600E,SKCM,3,Encorafenib_Cetuximab
TCGA-EB-A3Y6,BRAF,V600E,SKCM,3,Selumetinib
TCGA-EB-A3Y6,BRAF,V600E,SKCM,3,Encorafenib_Panitumumab
TCGA-ER-A19S,BRAF,V600E,SKCM,1,Vemurafenib
TCGA-ER-A19S,BRAF,V600E,SKCM,1,Vemurafenib_Atezolizumab_Cobimetinib
TCGA-ER-A19S,BRAF,V600E,SKCM,1,Dabrafenib_Trametinib
TCGA-ER-A19S,BRAF,V600E,SKCM,1,Dabrafenib
TCGA-ER-A19S,BRAF,V600E,SKCM,1,Encorafenib_Binimetinib
TCGA-ER-A19S,BRAF,V600E,SKCM,1,Trametinib
TCGA-ER-A19S,BRAF,V600E,SKCM,1,Vemurafenib_Cobimetinib
TCGA-ER-A19S,BRAF,V600E,SKCM,3,Encorafenib_Cetuximab
TCGA-ER-A19S,BRAF,V600E,SKCM,3,Selumetinib
TCGA-ER-A19S,BRAF,V600E,SKCM,3,Encorafenib_Panitumumab
